Connect your AI

Capricor Therapeutics CAPR Net margin

Net margin at other companies

PfizerPFE

15.7%—

Sarepta Therapeutics, Inc.SRPT

4.6%+2.4pp

PTC TherapeuticsPTCT

42.3%+27.4pp

Celldex TherapeuticsCLDX

-32,753.6%-35,519pp

VericelVCEL

7.3%+6.1pp

Viridian Therapeutics, Inc.VRDN

-508.5%-254pp

Other financials

Income statement

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

Market cap$1.71B+303%

Enterprise value$1.62B+308%

Profitability

Operating margin-778.8%-1,038pp

FCF margin-563.9%-954pp

Returns & leverage

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Calculated from Capricor Therapeutics’s reported figures.

net income/total revenue=-736.6%

Based on trailing twelve months.

The official record: Capricor Therapeutics’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Capricor Therapeutics's net margin?: Capricor Therapeutics (CAPR) reported net margin of -736.6% in Q3 2025.
How has Capricor Therapeutics's net margin changed year-over-year?: Capricor Therapeutics's net margin decreased by 401.6% year-over-year, from -146.9% to -736.6%.
What is the long-term trend for Capricor Therapeutics's net margin?: Over 2 years (2020 to 2024), Capricor Therapeutics's net margin has grown at a -79.7% compound annual growth rate (CAGR), from -4,401.9% to -181.7%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.